Blog

Upcoming webinar on “Overcoming Resistance” led by Michael Wick – The START Center for Cancer Research

Photo taken from events.zoom.us

Jun 14, 2024, 09:30

Upcoming webinar on “Overcoming Resistance” led by Michael Wick – The START Center for Cancer Research

The START Center for Cancer Research shared on LinkedIn: .

“Don’t miss our upcoming webinar, “Overcoming Resistance: Enhancing CDK4/6 Inhibitor Efficacy in Advanced Breast Cancer Treatment”, on July 9th at 3 PM ET.

Led by Michael Wick, Chief Scientific Officer at XenoSTART, this session will cover:
– Key insights into FDA-approved CDK4/6 inhibitors
– Mechanisms of resistance in ER+ breast cancer
– Strategies for re-sensitizing resistant patients through combination therapy

Source: The START Center for Cancer Research/LinkedIn

Advanced Breast Cancer cancer cancer treatment CDK4/6 inhibitors combination therapy ER+ breast cancer FDA approved Michael Wick OncoDaily Oncology resistant patients XenoSTART

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage